NL9220019A - Farmaceutische samenstelling. - Google Patents

Farmaceutische samenstelling. Download PDF

Info

Publication number
NL9220019A
NL9220019A NL9220019A NL9220019A NL9220019A NL 9220019 A NL9220019 A NL 9220019A NL 9220019 A NL9220019 A NL 9220019A NL 9220019 A NL9220019 A NL 9220019A NL 9220019 A NL9220019 A NL 9220019A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical composition
composition according
composition
bleeding
mucous membrane
Prior art date
Application number
NL9220019A
Other languages
English (en)
Dutch (nl)
Inventor
Tatyana Nikolaevna Sentsova
Viktor Semenovich Yakubovich
Ljudmila Pavlovna Raskina
Valery Alexandrovich Barabanov
Anatoly Afanasievich Ilchenko
Vladimir Grigorie Zhukhovitsky
Yanis Martynovich Mikelson
Anatoly Sergeevich Loginov
Nadezhda Timofeevn Melnichenko
Dzintra Alfredovna Leinasare
Leonid Iosifovich Aruin
Irina Anatolievna Smotrova
Lev Konstantinovich Sokolov
Viktor Vladimirovic Kondrashov
Tamara Mikhailovna Titova
Valeria Efimovna Selezneva
Vladimir Alexandrovich Makarov
Valery Vladimirovic Elmanovich
Original Assignee
Vnii Med Polimerov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vnii Med Polimerov filed Critical Vnii Med Polimerov
Publication of NL9220019A publication Critical patent/NL9220019A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NL9220019A 1992-04-10 1992-04-10 Farmaceutische samenstelling. NL9220019A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/RU1992/000074 WO1993020826A1 (en) 1992-04-10 1992-04-10 Pharmaceutical composition
RU9200074 1992-04-10

Publications (1)

Publication Number Publication Date
NL9220019A true NL9220019A (nl) 1994-04-05

Family

ID=20129712

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9220019A NL9220019A (nl) 1992-04-10 1992-04-10 Farmaceutische samenstelling.

Country Status (5)

Country Link
JP (1) JPH06508641A (es)
DE (1) DE4294862T1 (es)
GB (1) GB2272375B (es)
NL (1) NL9220019A (es)
WO (1) WO1993020826A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1269826B (it) * 1994-05-24 1997-04-15 Paolo Minoia Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
JP3114016B2 (ja) * 1998-05-15 2000-12-04 株式会社ホギメディカル 細胞接着促進効果を有する創傷止血材
GB9812278D0 (en) * 1998-06-09 1998-08-05 Bristol Myers Squibb Co Use of a wound dressing in the treatment of acute wounds
AU2003252694A1 (en) * 2002-07-26 2004-02-16 Mikasa Seiyaku Co., Ltd. External preparation
ES2358645T3 (es) * 2002-09-16 2011-05-12 Agennix Incorporated Composiciones de lactoferrina y métodos de tratamiento de la úlcera diabética.
PL2368553T3 (pl) 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AU2008233129B2 (en) 2007-03-29 2014-03-20 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
ES2540551T3 (es) 2007-03-29 2015-07-10 Wyeth Llc Antagonistas de receptores opioides periféricos y usos de los mismos
JP2010522756A (ja) 2007-03-29 2010-07-08 プロジェニックス ファーマシューティカルズ，インコーポレーテッド 結晶形およびその使用
CN101959892B (zh) 2008-02-06 2014-01-08 普罗热尼奇制药公司 (r),(r)-2,2’-二-甲基纳曲酮的制备和用途
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391799A (en) * 1980-02-15 1983-07-05 The United States Of America As Represented By The Secretary Of The Army Protective gel composition for treating white phosphorus burn wounds
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders

Also Published As

Publication number Publication date
WO1993020826A1 (en) 1993-10-28
JPH06508641A (ja) 1994-09-29
GB9325480D0 (en) 1994-03-09
DE4294862T1 (de) 1994-06-09
GB2272375B (en) 1996-02-14
GB2272375A (en) 1994-05-18

Similar Documents

Publication Publication Date Title
Jensen et al. The local implantation of sulfanilamide in compound fractures: A preliminary report
EP1863469B1 (en) A topical analgesic composition
NL9220019A (nl) Farmaceutische samenstelling.
Freedman et al. Commonly used topical oral wound dressing materials in dental and surgical practice–a literature review
PL202536B1 (pl) Zastosowanie preparatu aktywnej substancji szkliwa
AT15430U1 (de) Dentales Mittel auf Basis von Hyaluronan und Octenidindihydrochlorid
Lindstrom Complications from the use of absorbable hemostatic sponges
RU2470640C1 (ru) Средство для лечения воспалительных заболеваний полости рта и способ лечения воспалительных заболеваний полости рта
Murphy et al. Use of a high-molecular-weight carboxymethylcellulose in a tissue protective solution for prevention of postoperative abdominal adhesions in ponies
WO2005089699A1 (ja) 象牙質形成履髄剤
JP3899267B2 (ja) 皮膚、粘膜、器官または組織の疾患を治療するためのトシルクロルアミドの使用
RU2433171C1 (ru) Способ получения биологически активной субстанции из эмбрионально-яичной массы для приготовления противоожоговой пластины и противоожоговая пластина на его основе
RU2177314C2 (ru) Состав с антисептическими, репаративными и болеутоляющими свойствами
JP2003528147A (ja) 薬剤的ゲル組成物
WO2017060821A1 (en) Hemostatic composition
Fish Local and remote sequelae of infection in the parodontal sulcus
RU2784202C1 (ru) Мазевая сетчатая атравматическая повязка
IL101739A (en) Pharmaceutical compositions comprising alginic acid and a metal compound for use in the treatment of gastroenteritic diseases wounds and burns as well as a hemostatic agent
JP3620055B2 (ja) 創傷治療剤
Issrani et al. Exploring the properties of formocresol in dentistry---a comprehensive review.
Stashak Wound infection: contributing factors and selected techniques for prevention.
RU2288701C2 (ru) Состав для лечения альвеолита
RU2134572C1 (ru) Антисептическая мазь
Kukreja et al. Haemostatic agents in oral surgery: A brief review.
RU2145497C1 (ru) Средство для лечения гнойно-некротических процессов

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BV The patent application has lapsed